Cargando…

MicroRNAs in regulation of triple-negative breast cancer progression

PURPOSE: Dysregulation of miRNA profile has been associated with a broad spectrum of cellular processes underlying progression of various human malignancies. Increasing evidence suggests that specific microRNA clusters might be of clinical utility, especially in triple-negative breast carcinoma (TNB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piasecka, Dominika, Braun, Marcin, Kordek, Radzislaw, Sadej, Rafal, Romanska, Hanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Review – Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061037/ https://www.ncbi.nlm.nih.gov/pubmed/29923083 http://dx.doi.org/10.1007/s00432-018-2689-2

Ejemplares similares

A ‘Real-Life’ Experience on Automated Digital Image Analysis of FGFR2 Immunohistochemistry in Breast Cancer
por: Braun, Marcin, et al.
Publicado: (2020)

FGFs/FGFRs-dependent signalling in regulation of steroid hormone receptors – implications for therapy of luminal breast cancer
por: Piasecka, Dominika, et al.
Publicado: (2019)

Upregulation of HIF1-α via an NF-κB/COX2 pathway confers proliferative dominance of HER2-negative ductal carcinoma in situ cells in response to inflammatory stimuli
por: Piasecka, Dominika, et al.
Publicado: (2020)

Profiling of Invasive Breast Carcinoma Circulating Tumour Cells—Are We Ready for the ‘Liquid’ Revolution?
por: Braun, Marcin, et al.
Publicado: (2019)

Hormonal Receptor Status Determines Prognostic Significance of FGFR2 in Invasive Breast Carcinoma
por: Braun, Marcin, et al.
Publicado: (2020)

FGFR2-Driven Signaling Counteracts Tamoxifen Effect on ERα-Positive Breast Cancer Cells
por: Turczyk, Lukasz, et al.
Publicado: (2017)

FGF7/FGFR2–JunB signalling counteracts the effect of progesterone in luminal breast cancer
por: Mieczkowski, Kamil, et al.
Publicado: (2022)

Fibroblast growth factor signalling induces loss of progesterone receptor in breast cancer cells
por: Piasecka, Dominika, et al.
Publicado: (2016)

Interactions between FGFR2 and RSK2—implications for breast cancer prognosis
por: Czaplinska, Dominika, et al.
Publicado: (2016)

Subtype-Specific Tumour Immune Microenvironment in Risk of Recurrence of Ductal Carcinoma In Situ: Prognostic Value of HER2
por: Solek, Julia, et al.
Publicado: (2022)

Lack of CD151/integrin α3β1 complex is predictive of poor outcome in node-negative lobular breast carcinoma: opposing roles of CD151 in invasive lobular and ductal breast cancers
por: Romanska, Hanna M, et al.
Publicado: (2015)

MicroRNAs and Triple Negative Breast Cancer
por: D’Ippolito, Elvira, et al.
Publicado: (2013)

Ossifying fasciitis at an extraordinary site – a case report and analysis of diagnostic pitfalls
por: Kowalczyk, Łukasz, et al.
Publicado: (2019)

New progress in the role of microRNAs in the diagnosis and prognosis of triple negative breast cancer
por: Fu, Yeqin, et al.
Publicado: (2023)

The diagnostic challenge in pulmonary tumour embolism in cancer: a case report and literature review
por: Zielińska, Aleksandra, et al.
Publicado: (2021)

The Role of MicroRNAs in Cancer
por: Stahlhut Espinosa, Carlos E., et al.
Publicado: (2007)

Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing
por: Chang, Yao-Yin, et al.
Publicado: (2015)

Circulating microRNAs and their role in the immune response in triple-negative breast cancer
por: Piña-Sánchez, Patricia, et al.
Publicado: (2020)

Lamin B2 promotes the progression of triple negative breast cancer via mediating cell proliferation and apoptosis
por: Zhao, Cui-Cui, et al.
Publicado: (2021)

Bioinformatics identification of dysregulated microRNAs in triple negative breast cancer based on microRNA expression profiling
por: Chen, Junqing, et al.
Publicado: (2018)

MicroRNAs Expression in Triple Negative vs Non Triple Negative Breast Cancer in Tunisia: Interaction with Clinical Outcome
por: Medimegh, Imen, et al.
Publicado: (2014)

Modulatory Role of microRNAs in Triple Negative Breast Cancer with Basal-Like Phenotype
por: Angius, Andrea, et al.
Publicado: (2020)

Regulation of Inflammasome by microRNAs in Triple-Negative Breast Cancer: New Opportunities for Therapy
por: (Stămat), Liliana-Roxana Balahura, et al.
Publicado: (2023)

Role of ABCB1 in mediating chemoresistance of triple-negative breast cancers
por: Abd El-Aziz, Yomna S., et al.
Publicado: (2021)

Human microRNA similarity in breast cancer
por: Jing, Ying, et al.
Publicado: (2021)

The hedgehog pathway in triple‐negative breast cancer
por: Habib, Joyce G., et al.
Publicado: (2016)

MicroRNAs in the prognosis of triple-negative breast cancer: A systematic review and meta-analysis
por: Lü, Lingshuang, et al.
Publicado: (2017)

An integrated analysis of microRNAs regulating DNA damage response in triple-negative breast cancer
por: Kuthethur, Raviprasad, et al.
Publicado: (2023)

The role of EMT-related lncRNA in the process of triple-negative breast cancer metastasis
por: Zhang, Haomeng, et al.
Publicado: (2021)

Identification of tRNA‐derived small noncoding RNAs as potential biomarkers for prediction of recurrence in triple‐negative breast cancer
por: Feng, Wanting, et al.
Publicado: (2018)

Association of microRNAs and pathologic response to preoperative chemotherapy in triple negative breast cancer: preliminary report
por: Kolacinska, Agnieszka, et al.
Publicado: (2014)

MicroRNAs Involved in Carcinogenesis, Prognosis, Therapeutic Resistance, and Applications in Human Triple-Negative Breast Cancer
por: Ding, Lei, et al.
Publicado: (2019)

Advances in Understanding Mitochondrial MicroRNAs (mitomiRs) on the Pathogenesis of Triple-Negative Breast Cancer (TNBC)
por: Lin, Hung-Yu, et al.
Publicado: (2021)

MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics
por: Shea, Amanda, et al.
Publicado: (2016)

Concomitant activation of GLI1 and Notch1 contributes to racial disparity of human triple negative breast cancer progression
por: Siddharth, Sumit, et al.
Publicado: (2021)

Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K/Akt pathway
por: Xu, Yonggang, et al.
Publicado: (2021)

Osteoprotegerin expression in triple-negative breast cancer cells promotes metastasis
por: Weichhaus, Michael, et al.
Publicado: (2014)

Evaluation of BRCA1-related molecular features and microRNAs as prognostic factors for triple negative breast cancers
por: Boukerroucha, Meriem, et al.
Publicado: (2015)

A panel of eight microRNAs is a good predictive parameter for triple-negative breast cancer relapse
por: Hong, Hsiao-Chin, et al.
Publicado: (2020)

Laminin signals initiate the reciprocal loop that informs breast-specific gene expression and homeostasis by activating NO, p53 and microRNAs
por: Furuta, Saori, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rdec0l9l8qosfr2aer4rgfq05m